Eupraxia Pharmaceuticals Inc. Logo (CNW Group/Eupraxia Pharmaceuticals Inc.) The ... is designed to facilitate targeted drug ...
BRADENTON, Fla. and HOUSTON, Nov. 13, 2024 /PRNewswire/ -- Continuity Biosciences, LLC, a new bioscience company dedicated to developing and commercializing cutting-edge technologies for cell ...
Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...
Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, released its third quarter financial results ...
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical ...
The Canadian Press on MSN2d
'It's literally incredible': Swifties line up for merch ahead of Toronto concertsTORONTO - Hundreds of Taylor Swift fans lined up outside the gates of Toronto's Rogers Centre Wednesday, with hopes of ...
Taking Platkin literally, I don’t buy that virtually any high school students have followed the defanging of OPRA or the Elections Transparency Act. But his broader point rings true for a lot of very ...
Whether it’s Food and Drug Administration approval for commercialization of ... At the same time, trademarks protect a ...
Ijeoma Uchegbu discusses nanomedicine's role in improving medication adherence and developing non-addictive pain relief ...
Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on RenovoRx (RNXT – Research Report). The associated price target ...
The "Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback